Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
27-29 January, 2026
Not Confirmed
Not Confirmed
27-29 January, 2026
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
27-29 January, 2026
Industry Trade Show
Not Confirmed
27-29 January, 2026
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
Digital content

20 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260120068346/en/Agendia-Announces-NCCN-Guideline-Update-Recognizing-MammaPrint-to-Guide-Personalized-Anthracycline-Use-in-HRHER2--EarlyStage-Breast-Cancer

25 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251125677896/en/Agendia-to-Showcase-MammaPrint-and-BluePrint-Utility-in-Guiding-Anthracycline-Therapy-at-the-2025-San-Antonio-Breast-Cancer-Symposium

12 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250812214330/en/Agendia-Announces-Publication-in-JNCI-Cancer-Spectrum-Demonstrating-that-MammaPrint-Predicts-Chemotherapy-Benefit-in-HRHER2--Early-Breast-Cancer-Using-Real-World-Evidence-from-the-FLEX-Study

27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527845347/en/Agendia-to-Reveal-Novel-Breast-Cancer-Outcome-Data-Identifying-Genomic-Risk-and-Treatment-Disparities-Among-Diverse-Patient-Population-at-2025-ASCO-Annual-Meeting

15 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515469869/en/Agendia-to-Unveil-Novel-Data-on-Genomic-Risk-and-Treatment-Disparities-in-Early-Stage-Breast-Cancer-at-2025-ASCO-Annual-Meeting

08 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/08/3077424/0/en/Agendia-Named-2025-Best-Overall-Genomics-Company-By-MedTech-Breakthrough.html
ABOUT THIS PAGE